{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T17:55:08Z","timestamp":1770746108794,"version":"3.49.0"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,11,29]],"date-time":"2019-11-29T00:00:00Z","timestamp":1574985600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,11,29]],"date-time":"2019-11-29T00:00:00Z","timestamp":1574985600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Thymomas are known to be associated with myasthenia gravis and Good syndrome. Good syndrome is the association of thymoma with combined B cell and T cell immunodeficiency. The combination of all three diseases has not been reported. We discuss the therapeutic dilemma of immunosuppression in such a case.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Case presentation<\/jats:title>\n<jats:p>A 27-year-old Sinhalese man was evaluated for persistent cough which was associated with pleuritic chest pain and was found to have pleural-based lesions in his left hemithorax. Further evaluation confirmed these lesions to be implants from a thymoma. He subsequently developed myasthenia gravis and impending myasthenic crisis precipitated by pneumonia. He was found to have hypogammaglobulinemia with low B cell counts, confirming a diagnosis of Good syndrome. Treatment with intravenously administered broad-spectrum antibiotics, acetylcholinesterase inhibitors, orally administered glucocorticoids, plasma exchange, and intravenous immunoglobulin led to clinical improvement. He subsequently underwent thymectomy and debulking of the tumor and was maintained on regular intravenous immunoglobulins combined with low-dose prednisolone.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>Regular intravenous immunoglobulins combined with low-dose immunosuppression in addition to thymectomy appear to be safe when myasthenia gravis occurs in association with Good syndrome.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s13256-019-2289-z","type":"journal-article","created":{"date-parts":[[2019,11,29]],"date-time":"2019-11-29T01:02:41Z","timestamp":1574989361000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Thymoma complicated with myasthenia gravis and Good syndrome \u2013 a therapeutic conundrum: a case report"],"prefix":"10.1186","volume":"13","author":[{"given":"Shiran","family":"Paranavitane","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sumana","family":"Handagala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajiva","family":"De Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thashi","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,11,29]]},"reference":[{"key":"2289_CR1","doi-asserted-by":"crossref","unstructured":"Kreuter A, Tomi NS, Weiner SM, Huger M, Altmeyer P, Gambichler T. Mycophenolate sodium for subacute cutaneous lupus erythematosus resistant to standard therapy. 2007;156:1321\u20137.","DOI":"10.1111\/j.1365-2133.2007.07826.x"},{"issue":"9","key":"2289_CR2","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1001\/archinte.1985.00360090180027","volume":"145","author":"E Soppi","year":"1985","unstructured":"Soppi E, Eskola J, Roytta M, Veromaa T, Panelius M, Lehtonen A. Thymoma With Immunodeficiency (Good\u2019s Syndrome) Associated With Myasthenia Gravis and Benign IgG Gammopathy. Arch Intern Med. 1985;145(9):1704\u20137.","journal-title":"Arch Intern Med"},{"issue":"2","key":"2289_CR3","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1093\/cid\/civ269","volume":"61","author":"M Malphettes","year":"2015","unstructured":"Malphettes M, G\u00e9rard L, Galicier L, Boutboul D, Asli B, Szalat R, et al. Good Syndrome: An Adult-Onset Immunodeficiency Remarkable for Its High Incidence of Invasive Infections and Autoimmune Complications. Clin Infect Dis. 2015;61(2):13\u20139.","journal-title":"Clin Infect Dis"},{"key":"2289_CR4","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1136\/jcp.56.1.12","volume":"56","author":"P Kelleher","year":"2003","unstructured":"Kelleher P, Misbah SA. What is Good\u2019s syndrome? Immunological abnormalities in patients with thymoma. J Clin Pathol. 2003;56:12\u20136.","journal-title":"J Clin Pathol"},{"key":"2289_CR5","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.12688\/f1000research.8206.1","volume":"5","author":"WD Phillips","year":"2016","unstructured":"Phillips WD, Vincent A. Pathogenesis of myasthenia gravis : update on disease types, models, and mechanisms. F1000Research. 2016;5:1513.","journal-title":"F1000Research"},{"issue":"1\u20132","key":"2289_CR6","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.jns.2009.03.020","volume":"284","author":"T Chang","year":"2009","unstructured":"Chang T, Gunaratne P, Gamage R, Riffsy M, Vincent A. Journal of the Neurological Sciences MuSK-antibody-positive myasthenia gravis in a South Asian population. J Neurol Sci. 2009;284(1\u20132):33\u20135. https:\/\/doi.org\/10.1016\/j.jns.2009.03.020.","journal-title":"J Neurol Sci"},{"issue":"1\u20132","key":"2289_CR7","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.jns.2014.05.037","volume":"343","author":"T Chang","year":"2014","unstructured":"Chang T, Leite MI, Senanayake S, Gunaratna PS, Gamage R, Riffsy M, et al. Clinical and serological study of myasthenia gravis using both radioimmunoprecipitation and cell-based assays in a South Asian population. J Neurol Sci. 2014;343(1\u20132):82\u20137. https:\/\/doi.org\/10.1016\/j.jns.2014.05.037.","journal-title":"J Neurol Sci"},{"key":"2289_CR8","doi-asserted-by":"publisher","first-page":"2122","DOI":"10.1016\/S0140-6736(00)05186-2","volume":"357","author":"A Vincent","year":"2001","unstructured":"Vincent A, Palace J, Hilton-jones D. Myasthenia gravis. Lancet. 2001;357:2122\u20138.","journal-title":"Lancet."},{"issue":"2","key":"2289_CR9","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1097\/00005792-200103000-00005","volume":"80","author":"WAS Trober","year":"2001","unstructured":"Trober WAS, Undles CHCU, Ucey DARL. Infections in Patients with Immunodeficiency with Thymoma (Good Syndrome) Report of 5 Cases and Review of the Literature. Medicine (Baltimore). 2001;80(2):123\u201333.","journal-title":"Medicine (Baltimore)"},{"key":"2289_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4061\/2011\/847393","volume":"2011","author":"Nils Erik Gilhus","year":"2011","unstructured":"Gilhus NE, Owe JF, Hoff JM, Romi F, Skeie GOS, Aarli JA. Myasthenia Gravis : A Review of Available Treatment Approaches. Autoimmune Dis. 2011:1\u20136. https:\/\/doi.org\/10.4061\/2011\/847393.","journal-title":"Autoimmune Diseases"},{"issue":"4","key":"2289_CR11","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1097\/CND.0000000000000034","volume":"15","author":"NJ Silvestri","year":"2014","unstructured":"Silvestri NJ, Wolfe GI. Treatment-Refractory Myasthenia Gravis. J Clin Neuromuscul Dis. 2014;15(4):167\u201378.","journal-title":"J Clin Neuromuscul Dis"},{"issue":"9","key":"2289_CR12","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1002\/art.1780390906","volume":"39","author":"BD Pryor","year":"1996","unstructured":"Pryor BD, Bologna SG, Kahl LE. Risk factors for serious infection during treatment with cyclophosphamide and high-dose corticosteroids for systemic lupus erythematosus. Arhtritis Rheum. 1996;39(9):1475\u201382.","journal-title":"Arhtritis Rheum"},{"key":"2289_CR13","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1212\/01.wnl.0000259335.05741.5f","volume":"68","author":"MN Meriggioli","year":"2007","unstructured":"Meriggioli MN. IVIG in myasthenia gravis Getting enough \u201cbang for the buck.\u201d. Neurology. 2007;68:803\u20134.","journal-title":"Neurology."},{"issue":"3","key":"2289_CR14","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1097\/00002826-200105000-00010","volume":"24","author":"O Hilkevich","year":"2001","unstructured":"Hilkevich O, Drory VE, Chapman J, Korczyn AD. The Use of Intravenous Immunoglobulin as Maintenance Therapy in Myasthenia Gravis. Clin Neuropharmacol. 2001;24(3):173\u20136.","journal-title":"Clin Neuropharmacol"}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-019-2289-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13256-019-2289-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-019-2289-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,28]],"date-time":"2020-11-28T00:11:01Z","timestamp":1606522261000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmedicalcasereports.biomedcentral.com\/articles\/10.1186\/s13256-019-2289-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,29]]},"references-count":14,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["2289"],"URL":"https:\/\/doi.org\/10.1186\/s13256-019-2289-z","relation":{},"ISSN":["1752-1947"],"issn-type":[{"value":"1752-1947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,29]]},"assertion":[{"value":"13 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"348"}}